Minneapolis Heart Institute Foundation
Minneapolis, Minnesota 55417-1139
30 studies enrolling now · 132 studies all time
What they study most
AAA - Abdominal Aortic Aneurysm, ASCVD, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder), Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Acute Coronary Syndrome, Acute Decompensated Heart Failure, Acute Heart Failure, Acute Myocardial Infarction, Acute Myocarditis, Acute ST Segment Elevation Myocardial Infarction, Adverse Effect
Studies at this site
- Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy — Recruiting now
- ATLAS (AltaValve) Pivotal Trial — Recruiting now
- Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360) — Recruiting now
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- The TRICURE EFS Study — Recruiting now
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events — Recruiting now
- ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ — Recruiting now
- Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial — Recruiting now
- A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
- J-Valve Transfemoral Pivotal Study — Recruiting now
- Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation — Recruiting now
- Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US) — Recruiting now
- Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis — Recruiting now
- Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance — Recruiting now
- PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm — Recruiting now
- TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) — Recruiting now
- MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions — Recruiting now
- DESIFOR-EXPAND (MHIF) — Recruiting now
- Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) — Recruiting now
- Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI — Recruiting now
- Progress Complication — Recruiting now
- Progress Bifurcation Global Registry — Recruiting now
- Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. — Starting soon
- SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System — Completed
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Running, not enrolling
- The JenaValve ALIGN-AR LVAD Registry — Running, not enrolling
- Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention — Starting soon
- Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
- SPHERE Per-AF Post-Approval Study — Running, not enrolling
- Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis — Completed
- Alleviant ALLAY-HFrEF Study — Enrolling by invitation
- Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD — Running, not enrolling
- Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures — Enrolling by invitation
- Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy — Stopped early
- LOWER: Lomitapide Observational Worldwide Evaluation Registry — Completed
- Alleviant ALLAY-HF Study — Enrolling by invitation
- PERIGON Pivotal Trial — Running, not enrolling
- Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment — Running, not enrolling
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients — Running, not enrolling
- Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
- Precise Procedural and PCI Plan (P4) — Running, not enrolling
- Sapphire 3 CTO Study — Completed
- Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
- Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure — Running, not enrolling
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
- Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot) — Completed